Auteur R. B. GESKUS

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Highly active antiretroviral therapy (HAART) among HIV-infected drug users: a prospective cohort study of sexual risk and injecting behaviour

C. SMIT ; K. KINDENBURG ; R. B. GESKUS ; K. BRINKMAN ; R. A. COUTINHO ; M. PRINS | 2006
Périodique

Aims: To study sexual risk and injecting behaviour among HIV-infected drug users (DU) receiving highly active antiretroviral therapy (HAART). Design and setting: As part of an ongoing prospective cohort study, HIV-infected DU who commenced HAART[...]

Plus d'info

Ajouter à la sélection

Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users

C. H. S. VAN DEN BERG ; C. SMIT ; M. BAKKER ; R. B. GESKUS ; B. BERKHOUT ; JURRIAANS S. ; R. A. COUTINHO ; WOLTHERS K.C. ; M. PRINS | 2007
Périodique

ENGLISH : Abstract Injecting drug users (DU) are at high risk for hepatitis C virus (HCV) and HIV infections. To examine the prevalence and incidence of these infections over a 20-year period (19852005), the authors evaluated 1276 DU from the [...]

Plus d'info

Ajouter à la sélection

The effect of hepatitis C treatment and human immunodeficiency virus (HIV) co-infection on the disease burden of hepatitis C among injecting drug users in Amsterdam

A. MATSER ; A. URBANUS ; R. B. GESKUS ; M. KRETZSCHMAR ; M. XIRIDOU ; M. BUSTER ; R. COUTINHO ; M. PRINS | 2012
Dans Addiction (Vol.107, n°3, March 2012) Article : Périodique

AIMS: The hepatitis C virus (HCV) disease burden among injecting drug users (IDUs) is determined by HCV incidence, the long latency period of HCV, competing mortality causes, presence of co-infection and HCV treatment uptake. We examined the eff[...]

Plus d'info

Ajouter à la sélection

Lien externe